• Pharmesis flagged an expected net loss for 1HFY26, based on a preliminary assessment of unaudited condensed interim financial statements.
• The outlook covers the six months ended June 30, 2026.
• Management is finalizing the interim results, with full performance details due with the 1HFY26 financial statement release.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmesis International Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: NE31OEEX8T21JD4Q) on August 11, 2026, and is solely responsible for the information contained therein.